Concepedia

Arafath K. Najumudeen

AK

Statistics

Publications

17

Citations

1.4K

H-Index

15

Active since

2013

Affiliations

University of Glasgow(Current)

Cancer Research UK Scotland Institute

Beatson West of Scotland Cancer Centre

University of Oxford

The Francis Crick Institute

Arafath K. Najumudeen is an author at University of Glasgow specializing in oncology, medicine, and molecular oncology.

ORCID

Publications per year

2013–2025

17

Publications

17

The amino acid transporter SLC7A5 is required for efficient growth of KRAS-mutant colorectal cancer

Arafath K. Najumudeen, Fatih Ceteci, Sigrid K. Fey et al. · Nature Genetics · 2021 · 329 citations · Full text

, , +12

NOTUM from Apc-mutant cells biases clonal competition to initiate cancer

Dustin J. Flanagan, Nalle Pentinmikko, Kalle Luopajärvi et al. · Nature · 2021 · 252 citations · Full text

, , +12

Cancer-Associated Fibroblasts in Pancreatic Ductal Adenocarcinoma Determine Response to SLC7A11 Inhibition

George Sharbeen, Joshua A. McCarroll, Anouschka Akerman et al. · Cancer Research · 2021 · 132 citations · Full text

, , +17

Dynamic and adaptive cancer stem cell population admixture in colorectal neoplasia

Ester Gil Vázquez, Nadia Nasreddin, Gabriel N. Valbuena et al. · Cell stem cell · 2022 · 117 citations · Full text

, , +17

MNK Inhibition Sensitizes <i>KRAS</i> -Mutant Colorectal Cancer to mTORC1 Inhibition by Reducing eIF4E Phosphorylation and c-MYC Expression

John R. P. Knight, George Skalka, Nikola Vlahov et al. · Cancer Discovery · 2020 · 95 citations · Full text

, , +17

1–5 of 17